Sang Bong Ahn

Assistant Professor

Eulji University Hospital

South Korea

Research Interests

Explore related searches

Professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sang Bong Ahn is an Assistant Professor at Eulji Hospital in South Korea. His research focuses on liver diseases, particularly nonalcoholic fatty liver disease, metabolic dysfunction-associated steatotic liver disease, and hepatocellular carcinoma. He has contributed significantly to the field through various publications, including studies on noninvasive tests and serum biomarkers for liver conditions. Dr. Ahn aims to enhance screening and treatment approaches in hepatology through his ongoing research.

Articles (14)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (9)

Eileen Yoon

Hanyang University College of Medicine

SOUTH KOREA

View details

Dae Won Jun

Hanyang University

SOUTH KOREA

View details

Jonghyun Lee

University of Pennsylvania

UNITED STATES

View details

Assistant Prof. Dr.

Eulji University Hospital

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sang Bong Ahn

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort

Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments

Different Associations of Coffee Consumption with the Risk of Incident Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Liver Fibrosis

Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area

Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Reply: Is the METS-IR index an appropriate predictor for nonalcoholic fatty liver disease?

Reply: Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations.

Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-Analysis.

Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis

The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults

Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

Nationwide Data on the Characteristics of Linked-to-Care Chronic Hepatitis B in Korea

Do we need a new cut-off for FIB-4 in the metabolic dysfunction-associated fatty liver disease era?

Collaborators (9)

Eileen Yoon

Dae Won Jun

Jonghyun Lee

Sangsoo Han

Bora Lee

Do Seon Song

Sun Young Yim

Soon Sun Kim

Jun-Hyuk Lee

Make your next move.